Behçet’s syndrome (BS) is a rare neutrophilic vasculitis characterized by arterial and venous events, uniquely treated by immunosuppressants rather than anticoagulants. We demonstrated in BS an impaired fibrinogen structure and fibrin susceptibility to plasmin-induced lysis, mainly due to an enhanced neutrophils reactive oxygen species (ROS) production, supporting the notion that BS is a model of inflammation-induced thrombosis .
No takes yet. Share an insight, caveat, or question.
Emmi et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: